Patent directory · USPTO A61K / A61P
Patents matching “Maxim Pharmaceuticals, Inc.”
22 pharma patents match "Maxim Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 22 pharmaceutical patents matching "Maxim Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6893633
Methods and compositions for promoting the maturation of monocytes
expired -
US 6821510
Methods and compositions for promoting the maturation of monocytes
expired -
US 6790440
Methods and compositions for promoting the maturation of monocytes
expired -
US 6730692
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
expired -
US 6613788
Elevation of circulating blood histamine levels
expired -
US 6531120
Ophthalmic histamine compositions and uses thereof
expired -
US 6515003
Heterocyclic derivatives for the treatment of diabetes and other diseases
expired -
US 6498181
Synergistic tumorcidal response induced by histamine
expired -
US 6462067
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
expired -
US 6407133
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
expired -
US 6375946
Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
expired -
US 6350785
Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
expired -
US 6305380
Method for treatment of cancer and infectious disease
expired -
US 6270781
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
expired -
US 6245563
Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor
expired -
US 6242473
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
expired -
US 6221893
Administration of histamine for therapeutic purposes
expired -
US 6155266
Method for treatment of cancer and infectious disease
expired -
US 6080395
Method and composition for topical treatment of damaged tissue using histamine as active ingredient
expired -
US 6071509
Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
expired -
US 6071942
Elevation of circulating blood histamine levels
expired -
US 6063373
Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor
expired